Banner
Watch on-demand

mRNA-LNP digital symposium

#000
Overview
Overview
Speakers
Speaker
sciextext
text-left

Discover dedicated analytical solutions that will let you develop a path toward better mRNA-LNP-based therapeutics and vaccines.

Tune in to industry experts explaining how to move beyond analytical boundaries. Learn how to achieve more relevant information on in vitro transcribed (IVT) RNA and lipid nanoparticles (LNPs) for the next generation of therapeutics and vaccines.

registerform
Watch the webinars
https://forms.sciex.com/f/lp?campaign_id=7013w000002MOEGAA4&utm_term=G-%20WOD%20-%20Q124&primary_app=&market_vertical=Biopharma&sub_vertical=&utm_campaign=4.2%20cell%20and%20gene%20therapy%20workflow%20leadership&utm_source=SCIEX.com&solution=&utm_content=WOD&ty=https://sciex.com/events/ondemand-webinars/biopharma/mrna-lnp-digital-symposium-on-demand/thank-you&show_mv=true
one-column
1200pixel
Speakers
Speakers

Addressing stability challenges of mRNA-lipid nanoparticle therapies with formulation development

Jingtao Zhang, PhD and Daniel Turner
Scientific Director, Associate Scientist,
Catalent

Beyond mRNA - how advances in analytical techniques are enabling a revolution of the RNA drug landscape

Andrew Geall, PhD
Chief Development Officer and Co-Founder, Replicate Bioscience

Assessment of distinct mRNA-LNP formulations by multi-capillary gel electrophoresis (CGE-LIF) and implications for RNA-based drugs

Jeremie Parot, PhD
Research Scientist, SINTEF

Adducts and N-oxides: Understanding lipid nanoparticles (LNPs) for better mRNA-based drugs

Adam Crowe, PhD
Manager Analytical Development, Precision NanoSystems ULC

Better mRNA-LNPs: encapsulation efficiency, mRNA integrity and purity, lipid N-oxides and beyond

Jane Luo, PhD
Senior Scientist, SCIEX